AstraZeneca's antibody drug prevents Covid-19 in high-risk groups

Results from Astra's study found no one in the trial who received the cocktail contracted severe Covid-19 or died in relation to the disease, the company said in a statement Friday

from Latest News https://ift.tt/3CYQaGx
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share